Immunocore

@Immunocore

A leading TCR biotechnology company focused on delivering first-in-class biological therapies. See our community guidelines:

Oxfordshire, UK and Conshohocken, Pennsylvania, USA
Vrijeme pridruživanja: srpanj 2013.

Tweetovi

Blokirali ste korisnika/cu @Immunocore

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Immunocore

  1. Prikvačeni tweet
    4. velj

    On , our employees share how they support the cause, using this year’s theme of 🎗️

    Poništi
  2. 30. sij

    Metamorphopsia is one of the symptoms that a person with may present with. If you are a , visit to find out about other potential symptoms.

    Poništi
  3. 28. sij

    If you are a HCP interested in , you should check out . Bertil Damato has devised a mnemonic to assist specialists to distinguish between moles and melanomas of the eye. Please contact your doctor if you are concerned about moles or melanomas.

    Poništi
  4. 16. sij

    If you are a HCP and spot (UM), think differently. At all stages of disease, UM is intrinsically different to cutaneous melanoma. Visit to learn more.

    Poništi
  5. 14. sij

    Although is an ultra-rare disease, it is the most common primary intraocular malignancy and most commonly occurs in the choroid. If you are a HCP, learn more here:

    Poništi
  6. 10. sij

    Next week, our team is travelling to San Francisco to attend the 38th annual Healthcare Conference. We look forward to an informative and stimulating week!

    Poništi
  7. proslijedio/la je Tweet
    8. sij

    A HUGE thank you to for all their fundraising efforts last year🎉They helped raise money through different events, including: ∙ Find the Joker. ∙ Yorkshire Three Peaks ∙ Oxford Half Marathon Run. Thank you so much for all your hard work! The OcuMel Team x

    Poništi
  8. 8. sij

    In case you missed it, we created an educational resource to help educate front-line healthcare professionals about , a with a poor prognosis once it spreads beyond the eye. Learn more here:

    Poništi
  9. 6. sij

    An annual eye test, including dilation of the eye, examines more than your sight. Take care of your eyes and visit an eye care professional to get your annual dilated

    Poništi
  10. 30. pro 2019.

    What a fantastic year 2019 has been for us. Watch below for our highlights reel 😊

    Poništi
  11. 25. pro 2019.

    A very from everyone at Immunocore!

    Poništi
  12. 22. pro 2019.

    As the New Year approaches, we would like to thank people around the world who have participated in clinical trials. Because of you, we are able to better understand diseases and what’s needed to treat them.

    Poništi
  13. 19. pro 2019.

    To round out our employee question week, we asked Angela about what she would say to a young woman interested in pursuing a career in science.

    Poništi
  14. 18. pro 2019.

    Peter, Head of our Autoimmune Department, tells us why he joined Immunocore.

    Poništi
  15. 18. pro 2019.

    Today Ed is sharing his favourite aspect of his internship to date!

    Poništi
  16. 17. pro 2019.

    Why is cancer research so important? Shaad shares his thoughts with us.

    Poništi
  17. 16. pro 2019.

    Our team members are the backbone of what we do, and this week, we’d like you to get to know them, too. First up, we ask Sarah if she has a mentor that encouraged her to pursue a career in science.

    Poništi
  18. 13. pro 2019.

    Christmas jumpers as far as the eye can see! we are delighted to support your tradition. Which is your favourite? ☃️

    Poništi
  19. 12. pro 2019.

    We’ve worked with prominent leaders to create resources for detecting . If you are a HCP, learn more on .

    Poništi
  20. 9. pro 2019.

    Today we announced the start of the first-in-human clinical trial of the third developed using our ImmTAC® technology platform. IMC-C103C is focused on targeting tumours that express the protein MAGE-A4. Read more here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·